Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating genetically modified T cells in combination with decitabine for recurrent or refractory ovarian,…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with bevacizumab, with or without the anti-CD40 agonist CDX-1140, for recur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy [Phase 2]
Phase 2 trial evaluating a standardized AHCC extract in ovarian cancer patients on adjuvant chemotherapy; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: First in Human Study of IMGN151 in Recurrent Gynaecological Cancers [Phase 1]
This update covers the first-in-human Phase 1 study of IMGN151 in recurrent gynecologic cancers, sponsored by AbbVie, with the trial status …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy [NA]
Clinical trial update on prehabilitation care for women with advanced ovarian cancer undergoing neoadjuvant chemotherapy; the study is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer [NA]
Clinical trial investigating whether hepato-celiac lymphadenectomy affects survival in primary or relapsed epithelial ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating paclitaxel lipid suspension for platinum-resistant or refractory ovarian cancer and related platinum-res…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer [Phase 1]
A Phase 1 clinical trial of SCT-001 CAR T Cells Therapy for relapsed and refractory ovarian cancer and related peritoneal cancers is not yet…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecolog…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors [EARLY_Phase 1]
An early-phase (Phase 1) trial is evaluating a dual-targeting CAR-T therapy against HER2 and PD-L1 for solid tumors, including metastatic pe…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis
This ClinicalTrials.gov entry notes an international registration to investigate the risk of serous peritoneal carcinomatosis associated wit…